ID Now

Rapid detection of Streptococcus pyogenes in skin and soft tissue infections using the Abbott ID NOW™ Strep A 2 isothermal molecular assay.

Efficacy of swish and gargle and other collection methods with the use of Abbott ID NOW in COVID-19 detection.

Improving Antimicrobial Stewardship in Acute Sore Throat: Comparison of FeverPAIN and McIsaac Scores with Molecular Point of Care Testing Using Abbott ID NOW.

Implementation of isotermic PCR for detection of SARS-CoV-2 virus.

Does the Addition of Point-of-Care Testing Alter Antibiotic Prescribing Decisions When Patients Present with Acute Sore Throat to Primary Care? A Prospective Test of Change.

Neglected SARS-CoV-2 variants and potential concerns for molecular diagnostics: a framework for nucleic acid amplification test target site quality assurance.

Indian microbiology EQAS registered laboratory's capacity building and infection control practices during the COVID-19 pandemic in India: Lessons learnt and gaps identified.

Abbott ID NOW™ COVID-19 assay: do not discard the swab.

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals.

Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay.

Comparison of rapid nucleic acid amplification tests and rapid antigen tests for influenza in the emergency department.

Evaluation of the Analytical Sensitivity of a Molecular Point-of-Care Assay as Compared to 3 Lateral Flow Assays for Group A Streptococcus.

Comparison of the diagnostic accuracy of the Pluslife Mini Dock RHAM technology with Abbott ID Now and Cepheid GenXpert: A retrospective evaluation study.

Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.

The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid.

Diagnostic accuracy of a rapid nucleic acid test for group A streptococcal pharyngitis using saliva samples: protocol for a prospective multicenter study in primary care.

Evaluation of diagnostic performance of SARS-CoV-2 detection kits: a comparative study.

Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV.

Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples.

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2.

Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assays.

The Tokyo Metropolitan Government external quality assessment of SARS-CoV-2 nucleic acid amplification tests for clinics in 2023.

Accuracy of point-of-care SARS-CoV-2 detection using buccal swabs in pediatric emergency departments.

Clinical evaluation of a modified SARS-CoV-2 rapid molecular assay, ID NOW ™ COVID-19 2.0.

The diagnostic accuracy of the ID NOW COVID-19 point of care test in acute hospital admissions.

Analytical performance of the Abbott ID NOW 2.0 assay for SARS-CoV-2 detection in clinical samples from symptomatic patients.

The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays.

Characteristics of the ID-NOW™ test for the rapid detection of SARS-CoV-2.

Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery.

FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances.

Molecular Diagnostics for Group A Streptococcal Pharyngitis: Clinical and Economic Benefits in the Belgian Healthcare Context.